Youcare Pharmaceutical Group Co. Ltd. A (688658) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Youcare Pharmaceutical Group Co. Ltd. A (688658) has a cash flow conversion efficiency ratio of 0.051x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥173.51 Million ≈ $25.39 Million USD) by net assets (CN¥3.43 Billion ≈ $502.48 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Youcare Pharmaceutical Group Co. Ltd. A (688658) balance sheet quality index to measure how much of total assets are equity-financed.
Youcare Pharmaceutical Group Co. Ltd. A - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how Youcare Pharmaceutical Group Co. Ltd. A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Youcare Pharmaceutical Group Co. Ltd. A's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Youcare Pharmaceutical Group Co. Ltd. A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Youcare Pharmaceutical Group Co. Ltd. A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
DoubleU Games Co Ltd
KO:192080
|
0.041x |
|
INKON Life Technology Co Ltd
SHE:300143
|
0.027x |
|
Swissquote Group Holding SA
SW:SQN
|
0.300x |
|
XiAn ChenXi Aviation Technology Corp Ltd
SHE:300581
|
-0.005x |
|
Fujian Longma Envi Sanitation
SHG:603686
|
0.030x |
|
Inspur Software Co Ltd
SHG:600756
|
-0.037x |
|
Papa John's International Inc
NASDAQ:PZZA
|
-0.017x |
|
Ningbo Cixing
SHE:300307
|
-0.015x |
Annual Cash Flow Conversion Efficiency for Youcare Pharmaceutical Group Co. Ltd. A (2017–2025)
The table below shows the annual cash flow conversion efficiency of Youcare Pharmaceutical Group Co. Ltd. A from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see Youcare Pharmaceutical Group Co. Ltd. A market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥3.43 Billion ≈ $502.48 Million |
CN¥344.00 Million ≈ $50.34 Million |
0.100x | -18.05% |
| 2024-12-31 | CN¥3.58 Billion ≈ $524.59 Million |
CN¥438.24 Million ≈ $64.13 Million |
0.122x | -44.01% |
| 2023-12-31 | CN¥3.60 Billion ≈ $526.45 Million |
CN¥785.49 Million ≈ $114.94 Million |
0.218x | +820.23% |
| 2022-12-31 | CN¥4.00 Billion ≈ $584.90 Million |
CN¥-121.17 Million ≈ $-17.73 Million |
-0.030x | -123.11% |
| 2021-12-31 | CN¥3.93 Billion ≈ $574.66 Million |
CN¥515.24 Million ≈ $75.40 Million |
0.131x | -32.57% |
| 2020-12-31 | CN¥3.59 Billion ≈ $524.73 Million |
CN¥697.66 Million ≈ $102.09 Million |
0.195x | -32.65% |
| 2019-12-31 | CN¥1.12 Billion ≈ $164.59 Million |
CN¥324.94 Million ≈ $47.55 Million |
0.289x | +26.35% |
| 2018-12-31 | CN¥842.76 Million ≈ $123.32 Million |
CN¥192.70 Million ≈ $28.20 Million |
0.229x | -24.22% |
| 2017-12-31 | CN¥711.86 Million ≈ $104.17 Million |
CN¥214.81 Million ≈ $31.43 Million |
0.302x | -- |
About Youcare Pharmaceutical Group Co. Ltd. A
Youcare Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It offers drugs in various forms, such as injection, lyophilized powder injection, pills, tablets, capsules, ointments, creams, granules, etc. The company provides drugs in various categories, including covering cardio-cerebrovascular, antivirals, central… Read more